|
DDY391 Clinical Trials
2 actively recruiting trials across 2 locations
No change since September 2026
Pipeline
Phase 2: 2
Top Sponsors
- Novartis Pharmaceuticals2
Indications
- Arthritis2
- Moderate to Severe Psoriatic Arthritis1
- Sjögren's Disease1
Clearwater, Florida1 trial
A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease
Clinical Res Of W Florida
Phase 2
Memphis, Tennessee1 trial
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.